跳至主要内容
临床试验/CTRI/2014/11/005185
CTRI/2014/11/005185已完成3 期

Preclinical and Clinical study on â??MATHUMEGAMâ?? (Type-2 Diabetes Mellitus) and the drug of choice is â??ATTHIPPATTAIYATHI KASAYAMâ?? (Internal).

national institute of siddha0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Polydipsia,
  • Polyphagia,
  • Weight gain(obesity),
  • Burning feet,
  • genital pruritus,
  • Diabetes defined as those patients with Fasting plasma glucose level 126 to 180 mg/dl,
  • 2 hours postprandial plasma glucose level 200 to 300 mg/dl

排除标准

  • Diabetic complications like microvascular and macrovascular complications etc,
  • Cardiac diseases,
  • Pulmonary diseases,
  • Renal diseases,
  • Thyroid dysfunctions,
  • Gestational diabetes,
  • Other endocrine abnormalities,
  • Patient who are not willing to give blood sample

研究者

相似试验